Bone Graft and Substitute Market Will Record an Upsurge in Revenue

Stratview Research has published a new report on the Bone Graft and Substitute Market, segmented By Material Type (Allografts, Synthetics, Other), Application (Craniomaxillofacial, Dental, Foot & Ankle, Joint Reconstruction, Long Bone, Spinal Fusion), End-User (Hospital, Dental Clinic), and Region.

This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global artificial intelligence as a service market.

Market Highlights

The Bone Graft and Substitute Market is projected to grow from USD 3.05 billion in 2021 to USD 4.69 billion by 2028 at a CAGR of 6.24% during the forecast period of 2022-2028.

Covid Impact

Covid-19 has impacted the market dynamics, competition, and global supply chain of every possible market one can think of. The revenues for many, have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operations and strategy will sustain and beat the competition.

Segmentation –

This report studies the Bone Graft and Substitute Market and has segmented the market in a few ways, keeping in mind the concentration of all the stakeholders across the value chain. Following are the ways in which the market has been segmented in the report:

By end-user, the bone graft and substitute market has been bifurcated into hospitals and dental clinics. The hospital segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period. The segment can be attributed to the availability of required infrastructure, technical expertise, and skilled staff.

By region, the North American market accounted for the largest market share in 2020 and is projected to grow at a robust CAGR during the review period. This can be attributed to the rising number of people suffering from orthopedic disorders coupled with expanding geriatric populace and the presence of key market players such as Zimmer Biomet (US) and Dentsply Sirona (US). The market growth in Asia-Pacific is expected to be driven by the increasing incidence of accidental injuries and rising medical tourism in developing countries.

Following are the key players in the Bone Graft and Substitute Market:

• Zimmer Biomet (US)
• Medtronic plc (Ireland)
• Aimedic MMT (Japan)
• Dentsply Sirona (US)
• DePuy Synthes (US)
• Straumann (Switzerland)
• Botiss medical AG (Germany)
• Biomatlante (France)
• Maxigen Biotech Inc. (Taiwan)
• B. Braun (Germany)
• BioMimetic Therapeutics, LLC (US)
• CryoLife, Inc. (US)
• Globus Medical, Inc. (US)
• GRAFTYS (France)
• Integra Life Sciences (US)
• Johnson & Johnson (US).

To know more about the covid impact on the market, click here: https://www.stratviewresearch.com/Request-Sample/2424/Bone-Graft-and-Substitute-Market.html#form

About Stratview Research-

Stratview Research is a global market intelligence firm having a strong team of industry veterans and research analysts. Stratview Research has been serving multiple clients across a wide array of industries. Our services cover a broad spectrum of industries including but not limited to Energy Chemicals, Advanced Materials, Automotive, and Aerospace. At Stratview, we believe in building long term relations with our clients.

Connect with our team here–
https://www.stratviewresearch.com/contact

Or

Call us @:  +1-313-307-4176

Article source: https://article-realm.com/article/Business/50471-Bone-Graft-and-Substitute-Market-Will-Record-an-Upsurge-in-Revenue.html